SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 439.96 |
| Enterprise Value ($M) | 316.30 |
| Book Value ($M) | 349.10 |
| Book Value / Share | 4.25 |
| Price / Book | 1.26 |
| NCAV ($M) | 190.77 |
| NCAV / Share | 2.32 |
| Price / NCAV | 2.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.40 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.39 |
| Current Ratio | 5.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 340.83 |
| Assets | 499.15 |
| Liabilities | 150.06 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 78.12 |
| Operating Income | -169.18 |
| Net Income | -153.22 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -132.18 |
| Cash from Investing | -3.73 |
| Cash from Financing | 118.04 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | State Street Corp | 10.71 | 72.80 | |
| 13G/A | Deep Track Capital, LP | 6.70 | 21.80 | |
| 13G/A | Vanguard Group Inc | 10.36 | 23.11 | |
| 13G/A | BlackRock Inc. | 9.60 | 6.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 198,581 | 1,173,972 | 16.92 | |
| 193,340 | 627,244 | 30.82 | |
| 284,802 | 560,700 | 50.79 | |
| 235,836 | 572,347 | 41.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DNLI – Denali Therapeutics Inc. | DSGN – Design Therapeutics, Inc. |
| DVAX – Dynavax Technologies Corporation | ELEV – Elevation Oncology, Inc. |
| ELVN – Enliven Therapeutics, Inc. |